透過您的圖書館登入
IP:18.117.186.92
  • 期刊

Prognosis of Patients with DM/PM Requiring Intensive Care Due to Acute Respiratory Failure

皮肌炎及多發性肌炎病人因急性呼吸衰竭需要加護醫療之預後

摘要


背景:目前為止,尚沒有關於皮肌炎(dermatomyositis)及多發性肌炎(polymyositis)病人因急性呼吸衰竭需要加護醫療之預後之報告。本文以回溯性分析此類病人的臨床病程及預後。 方法:我們回顧自1985年1月至2004年12月間,曾住進加護病房病人的醫療紀錄,將診斷符合皮肌炎多發性肌炎,並且發生呼吸衰竭而住到加護病房的病人納入研究。皮肌炎/多發性肌炎之診斷,是根據Bohan及Peter二人所訂定的診斷條件。 結果:在研究期間,共有19位診斷為皮肌炎/多發性肌炎病人,因呼吸衰竭住到加護病房。其中有8位病人被診斷有皮肌炎/多發性肌炎相關之間質性肺病。呼吸衰竭的發生,平均在皮肌炎/多發性肌炎診斷後的14個月發生。導致呼吸衰竭的原因有:肺炎(n=14),間質性肺病(n=5),通氣衰竭(ventilatory failure)(n=2),及急性肺水腫(n=1)。最常發生的併發症為敗血性休克(n=16),其次為急性呼吸窘迫症候群(n=13)及急性腎衰竭(n=9)。共有12位病患死亡,死亡率63%。其死因包括:肺炎(n=7)、敗血性休克(n=3)、間質性肺病併發呼吸衰竭(n=2)、肝衰竭(n=1)。死亡病人中,92%發生急性呼吸窘迫症候群;而所有間質性肺病之患者,均發生急性呼吸窘迫症候群。後者常對免疫抑制治療無效;反之那些因通氣衰竭的病患,對治療則有不錯的反應。 結論:皮肌炎/多香性肌炎病人,併發呼吸衰竭而需要加護醫療照顧者,死亡率極高,最常見的死因為肺炎。

並列摘要


Background: The prognosis of patients with dermatomyositis/polymyositis (DM/PM) requiring intensive care for acute respiratory failure has not been reported. A retrospective study was conducted to analyze the clinical course and outcome of these patients. Methods: Medical records were reviewed for patients admitted to the intensive care unit from January 1985 to December 2004. The diagnosis of DM/PM was based upon Bohan and Peter's criteria, and those patients with respiratory failure as the indication for ICU admission were enrolled. Results: Nineteen patients with DM/PM were admitted to the ICU because of respiratory failure during the study period. Eight patients were diagnosed with interstitial lung disease. Respiratory failure developed within a mean of 14 months after the diagnosis of DM/PM. The causes of respiratory failure were: pneumonia (n=14), interstitial lung disease (ILD) (n=5), ventilatory failure (n=2), and acute lung edema (n=1). The most common complications were septic shock (n=16), followed by ARDS (n=13), and acute renal failure (n=9). Twelve patients died, with a mortality rate of 63%. The causes of death were: pneumonia (n=6), septic shock (n=3), ILD with respiratory failure (n=2), and hepatic failure (n=1). Ninety-two percent of the expired patients and all of those with ILD developed ARDS. ILD patients were often refractory to immunosuppressive treatment while patients with ventilatory failure had a good response to therapy. Conclusion: Patients with DM/PM and respiratory failure requiring ICU admission had an extremely high mortality rate, and most died of pneumonia.

延伸閱讀